These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16710842)

  • 1. The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers.
    Hennard C; Pfuhl T; Buettner M; Becker KF; Knöfel T; Middeldorp J; Kremmer E; Niedobitek G; Grässer F
    J Pathol; 2006 Aug; 209(4):430-5. PubMed ID: 16710842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus in breast cancer: artefact or aetiological agent?
    Murray PG
    J Pathol; 2006 Aug; 209(4):427-9. PubMed ID: 16906594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease.
    Grässer FA; Murray PG; Kremmer E; Klein K; Remberger K; Feiden W; Reynolds G; Niedobitek G; Young LS; Mueller-Lantzsch N
    Blood; 1994 Dec; 84(11):3792-8. PubMed ID: 7949135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.
    Murray PG; Lissauer D; Junying J; Davies G; Moore S; Bell A; Timms J; Rowlands D; McConkey C; Reynolds GM; Ghataura S; England D; Caroll R; Young LS
    Cancer Res; 2003 May; 63(9):2338-43. PubMed ID: 12727860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.
    Oudejans JJ; Dukers DF; Jiwa NM; van den Brule AJ; Grässer FA; de Bruin PC; Horstman A; Vos W; van Gorp J; Middeldorp JM; Meijer CJ
    J Clin Pathol; 1996 Nov; 49(11):897-902. PubMed ID: 8944608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
    Zhang B; Zong Y; He J; Zhong B; Lin S
    Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma.
    Herrmann K; Niedobitek G
    Breast Cancer Res; 2003; 5(1):R13-7. PubMed ID: 12559053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.
    Ayadi W; Karray-Hakim H; Feki L; Khabir A; Boudawara T; Ghorbel A; Daoud J; Frikha M; Hammami A
    J Med Virol; 2009 Aug; 81(8):1412-21. PubMed ID: 19551836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated automated multispectral imaging technique that simultaneously detects and quantitates viral RNA and immune cell protein markers in fixed sections from Epstein-Barr virus-related tumours.
    Wee YTF; Alkaff SMF; Lim JCT; Loh JJH; Hilmy MH; Ong C; Nei WL; Jain A; Lim A; Takano A; Azhar R; Wan WK; Newell E; Yeong J; Lim TKH
    Ann Diagn Pathol; 2018 Dec; 37():12-19. PubMed ID: 30218928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report.
    Hila L; Farah F; Ayari H; Ferjaoui M; Dehria W; Ben Jilani S
    Pathol Biol (Paris); 2009 Jul; 57(5):427-9. PubMed ID: 18835109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.
    Kanavaros P; Jiwa NM; de Bruin PC; van der Valk P; Noorduyn LA; van Heerde P; Gordijn R; Horstman A; Mullink R; Willemze R
    J Pathol; 1992 Nov; 168(3):307-15. PubMed ID: 1335046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No significant association of Epstein-Barr virus infection with invasive breast carcinoma.
    Chu PG; Chang KL; Chen YY; Chen WG; Weiss LM
    Am J Pathol; 2001 Aug; 159(2):571-8. PubMed ID: 11485915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
    Perez EM; Foley J; Tison T; Silva R; Ogembo JG
    Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.